Abstract
Abstract
Background
Syringe services programs (SSPs) remain highly effective, cost-saving interventions for the prevention of blood-borne infections among people who inject drugs. However, there have been restrictions regarding financial resources allocated to these programs, particularly in the US South. This study aimed to provide cost data regarding the implementation and first-year operations of an academic-based SSP utilizing fixed and mobile strategies, including the integration of onsite wound care.
Methods
We conducted a micro-costing study that retrospectively collected detailed resource utilization and unit cost data for both the fixed and mobile SSP strategies, including onsite wound care, from both healthcare and societal perspectives. A three-step approach was used to identify, measure, and value intervention costs, and cost components were categorized into implementation, variable program, and time-dependent costs. Sensitivity analysis was performed to examine the impact of SSP operational changes (i.e., needs-based distribution and opt-out HIV/HCV testing) on the cost-per-participant. Cost data we presented as overall cost and cost-per-participant adjusted to 2017 US dollars.
Results
A total of 452 and 129 participants enrolled in fixed and mobile SSP services, respectively. The total cost associated with implementation and first year operations for the fixed site was $407,217.22 or $729.72 per participant and $311,625.52 or $2415.70 per participant for the mobile unit. The largest cost component for both modalities was time-dependent costs (personnel and overhead), while intervention materials (syringes, injection equipment, naloxone) were less than 15% of the total program cost.
Discussion/conclusion
Implementation and operation of new SSP models continue to be low cost compared to treatment for the multitude of harms PWID face without access to evidence-based prevention. Future cost-effectiveness and cost–benefit analyses integrating a comprehensive SSP model within an academic institution, including onsite wound care and other medical services, will provide a more comprehensive understanding of this model, and state-level policy action must be taken to lift the prohibition of state and local funds for the implementation, sustainability, and maintenance of these programs in Florida.
Funder
National Institute on Drug Abuse
Division of Cancer Prevention, National Cancer Institute
National Institute of Mental Health
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Public Health, Environmental and Occupational Health,Medicine (miscellaneous)
Reference67 articles.
1. Spencer, M., et al., Drug overdose deaths involving fentanyl, 2011–2016. 2019.
2. Kariisa M, et al. Drug overdose deaths involving cocaine and psychostimulants with abuse potential—United States, 2003–2017. Morb Mortal Wkly Rep. 2019;68(17):388.
3. Wilson, N., Drug and opioid-involved overdose deaths—United States, 2017–2018. MMWR. Morbidity and Mortality Weekly Report, 2020. 69.
4. CDC. Provisional Drug Overdose Death Counts. 2020 [cited 2020 October 12]; Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
5. CDC. 12 Month-ending Provisional Number of Drug Overdose Deaths. 2021 [cited 2021 October 22nd ]; Available from: https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.